Piramal Pharma Statistics

Total Valuation

Piramal Pharma has a market cap or net worth of INR 290.39 billion. The enterprise value is 333.75 billion.

Market Cap	290.39B
Enterprise Value	333.75B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

Piramal Pharma has 1.33 billion shares outstanding. The number of shares has increased by 8.30% in one year.

Current Share Class	1.33B
Shares Outstanding	1.33B
Shares Change (YoY)	+8.30%
Shares Change (QoQ)	-7.69%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	23.71%
Float	607.57M

Valuation Ratios

The trailing PE ratio is 318.66 and the forward PE ratio is 58.80. Piramal Pharma's PEG ratio is 0.78.

PE Ratio	318.66
Forward PE	58.80
PS Ratio	3.13
PB Ratio	3.57
P/TBV Ratio	7.19
P/FCF Ratio	127.41
P/OCF Ratio	32.54
PEG Ratio	0.78

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.20, with an EV/FCF ratio of 146.43.

EV / Earnings	366.23
EV / Sales	3.59
EV / EBITDA	20.20
EV / EBIT	39.91
EV / FCF	146.43

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.60.

Current Ratio	1.54
Quick Ratio	0.76
Debt / Equity	0.60
Debt / EBITDA	3.07
Debt / FCF	21.31
Interest Coverage	1.81

Financial Efficiency

Return on equity (ROE) is 1.14% and return on invested capital (ROIC) is 3.73%.

Return on Equity (ROE)	1.14%
Return on Assets (ROA)	3.08%
Return on Invested Capital (ROIC)	3.73%
Return on Capital Employed (ROCE)	6.41%
Revenue Per Employee	13.82M
Profits Per Employee	135,630
Employee Count	6,719
Asset Turnover	0.60
Inventory Turnover	1.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.67% in the last 52 weeks. The beta is 0.10, so Piramal Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	+42.67%
50-Day Moving Average	213.46
200-Day Moving Average	224.33
Relative Strength Index (RSI)	54.32
Average Volume (20 Days)	3,514,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Piramal Pharma had revenue of INR 92.86 billion and earned 911.30 million in profits. Earnings per share was 0.68.

Revenue	92.86B
Gross Profit	60.54B
Operating Income	7.63B
Pretax Income	4.15B
Net Income	911.30M
EBITDA	15.39B
EBIT	7.63B
Earnings Per Share (EPS)	0.68

Full Income Statement

Balance Sheet

The company has 5.21 billion in cash and 48.56 billion in debt, giving a net cash position of -43.35 billion or -32.70 per share.

Cash & Cash Equivalents	5.21B
Total Debt	48.56B
Net Cash	-43.35B
Net Cash Per Share	-32.70
Equity (Book Value)	81.25B
Book Value Per Share	61.40
Working Capital	20.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 8.92 billion and capital expenditures -6.64 billion, giving a free cash flow of 2.28 billion.

Operating Cash Flow	8.92B
Capital Expenditures	-6.64B
Free Cash Flow	2.28B
FCF Per Share	1.72

Full Cash Flow Statement

Margins

Gross margin is 65.20%, with operating and profit margins of 8.22% and 0.98%.

Gross Margin	65.20%
Operating Margin	8.22%
Pretax Margin	4.47%
Profit Margin	0.98%
EBITDA Margin	16.57%
EBIT Margin	8.22%
FCF Margin	2.45%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.05%.

Dividend Per Share	0.11
Dividend Yield	0.05%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	15.88%
Buyback Yield	-8.30%
Shareholder Yield	-8.25%
Earnings Yield	0.31%
FCF Yield	0.78%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a